Temperatures change in a treatment device under operate can affect the stability of the device. Cooling the device may help stability, however, cooling device are bulky and require additional energy to operate. Accordingly, new approaches to monitoring ultrasound energy that is transmitted into a region of interest are needed.
Various embodiments described herein provide methods and systems for monitoring ultrasound energy. Some embodiments provide a method of providing ultrasound energy having a stable power output. The method can comprise providing ultrasound energy from a ultrasound transducer; determining a power level threshold of the ultrasound energy; monitoring a power level of the ultrasound energy over time of the ultrasound energy; communicating a power level to a controller; adjusting the frequency of the ultrasound energy upon a change in the power level; and maintaining the power level threshold of the ultrasound energy.
In some embodiments, the method can further comprise emitting the ultrasound energy at a specific frequency and correcting the frequency to the specific frequency upon a change in the power level. In some embodiments, the method can comprise changing power provided to a transducer providing the ultrasound energy based on the adjusting the frequency of the ultrasound energy. In some embodiments, the method can comprise terminating the providing the ultrasound energy upon a change of the power level above the power level threshold.
Some embodiments provide a method of providing ultrasound energy having a stable power output. The method can comprise providing ultrasound energy from an ultrasound transducer; determining a power level threshold of the ultrasound energy; monitoring a temperature of the ultrasound transducer over time; communicating the temperature to a controller; adjusting the frequency of the ultrasound energy upon a change in the temperature; and maintaining the power level threshold of the ultrasound energy.
The present disclosure will become more fully understood from the description and the accompanying drawings, wherein:
The following description is merely exemplary in nature and is in no way intended to limit the various embodiments, their application, or uses. As used herein, the phrase “at least one of A, B, and C” should be construed to mean a logical (A or B or C), using a non-exclusive logical “or.” As used herein, the phrase “A, B and/or C” should be construed to mean (A, B, and C) or alternatively (A or B or C), using a non-exclusive logical “or.” It should be understood that steps within a method may be executed in different order without altering the principles of the present disclosure.
The drawings described herein are for illustrative purposes only of selected non-limiting embodiments and not all possible implementations, and are not intended to limit the scope of any of the various embodiments disclosed herein or any equivalents thereof. It is understood that the drawings are not drawn to scale. For purposes of clarity, the same reference numbers will be used in the drawings to identify similar elements.
The various embodiments may be described herein in terms of various functional components and processing steps. It should be appreciated that such components and steps may be realized by any number of hardware components configured to perform the specified functions. For example, various embodiments may employ various medical treatment devices, visual imaging and display devices, input terminals and the like, which may carry out a variety of functions under the control of one or more control systems or other control devices. In addition, the embodiments may be practiced in any number of medical contexts and that the various embodiments relating to a method and system for acoustic energy deposition in tissue, as described herein, are merely indicative of one of the many applications for the invention. For example, the principles, features and methods discussed may be applied to any medical application. Further, various aspects of the various embodiments may be suitably applied to cosmetic applications. Moreover, some of the embodiments may be applied to cosmetic enhancement of skin and/or various soft tissue layers.
Various embodiments provide methods and systems to adjust a temperature of a transducer, in order to maintain maximum efficiency of power applied by the transducer. Some embodiments provide methods and systems to minimize or eliminate temperature saturation of a transducer during the delivery of power to the transducer. In some embodiments, methods and systems can control a temperature of a transducer to maintain a desired frequency of energy transmission at a maximum power.
Some embodiments provide a method of providing ultrasound energy having a stable power output. The method can comprise providing ultrasound energy from a ultrasound transducer; determining a power level threshold of the ultrasound energy; monitoring, a power level of the ultrasound energy over time of the ultrasound energy; communicating a power level to a controller; adjusting the frequency of the ultrasound energy upon a change in the power level; and maintaining the power level threshold of the ultrasound energy.
In some embodiments, the method can further comprise emitting the ultrasound energy at a specific frequency and correcting the frequency to the specific frequency upon a change in the power level. In some embodiments, the method can comprise changing power provided to a transducer providing the ultrasound energy based on the adjusting the frequency of the ultrasound energy. In some embodiments, the method can comprise terminating the providing the ultrasound energy upon a change of the power level above the power level threshold.
Some embodiments provide a method of providing ultrasound energy having a stable power output. The method can comprise providing ultrasound energy from an ultrasound transducer; determining a power level threshold of the ultrasound energy; monitoring a temperature of the ultrasound transducer over time; communicating the temperature to a controller; adjusting the frequency of the ultrasound energy upon a change in the temperature; and maintaining the power level threshold of the ultrasound energy.
In some embodiments, the method can further comprise determining a temperature threshold of the ultrasound transducer and terminating the providing ultrasound energy when the temperature is above the temperature threshold.
In some embodiments, the method can further comprise emitting the ultrasound energy at a specific frequency and correcting the frequency to the specific frequency upon the change of temperature. In some embodiments, the method can comprise terminating the providing the ultrasound energy upon a change of the power level above the power level threshold. In some embodiments, the method can further comprise determining a temperature threshold of the ultrasound transducer and terminating the providing ultrasound energy when a temperature of the ultrasound transducer is above the temperature threshold.
Some embodiments provide a method of providing ultrasound energy having a stable power output. The method can comprise providing ultrasound energy from an ultrasound transducer; determining a voltage threshold of the ultrasound energy; monitoring a voltage of the ultrasound transducer over time communicating the voltage to a controller; adjusting the frequency of the ultrasound energy upon a change in the voltage; and maintaining the power level threshold of the ultrasound energy.
In some embodiments, the method can thither comprise determining a temperature threshold of the ultrasound transducer and terminating the providing ultrasound energy when the temperature of the ultrasound transducer is above the temperature threshold.
In some embodiments, the method can further comprise emitting the ultrasound energy at a specific frequency and correcting the frequency to the specific frequency upon the change of voltage. In some embodiments, the method can comprise terminating the providing the ultrasound energy upon a change of the power level above the power level threshold.
Some embodiments provide a method of providing ultrasound energy having a stable power output. The method can comprise providing ultrasound energy from a ultrasound transducer; determining a voltage threshold of the ultrasound energy; monitoring a voltage of the ultrasound transducer over time; communicating the voltage to a controller; adjusting the frequency of the ultrasound energy upon an change in the voltage; monitoring a power level of the ultrasound energy over time of the ultrasound energy; communicating a power level to a controller; adjusting the frequency of the ultrasound energy upon a change in the power level; and maintaining the power level threshold of the ultrasound energy.
In some embodiments, the method can further comprise determining a temperature threshold of the ultrasound transducer and terminating the providing ultrasound energy when the temperature of the ultrasound transducer is above the temperature threshold.
In some embodiments, the method can further comprise emitting the ultrasound energy at a specific frequency and correcting the frequency to the specific frequency upon the change of voltage. In some embodiments, the method can comprise terminating the providing the ultrasound energy upon a change of the power level above the power level threshold.
Some embodiments provide a method of providing ultrasound energy having a stable power output. The method can comprise providing ultrasound energy from a ultrasound transducer; monitoring a power level of the ultrasound energy over time of the ultrasound energy; communicating a power level to a controller; adjusting the frequency of the ultrasound energy upon a change in the power level; monitoring a temperature of the ultrasound transducer over time; communicating the temperature to a controller; adjusting the frequency of the ultrasound energy upon an change in the temperature; and maintaining the power level threshold of the ultrasound energy.
In some embodiments, the method can further comprise determining a temperature threshold of the ultrasound transducer and terminating the providing ultrasound energy when the temperature of the ultrasound transducer is above the temperature threshold.
In some embodiments, the method can further comprise emitting the ultrasound energy at a specific frequency and correcting, the frequency to the specific frequency upon the change of voltage. In some embodiments, the method can comprise terminating the providing the ultrasound energy upon a change of the power level above the power level threshold.
Some embodiments provide a method of providing ultrasound energy having a stable power output. The method can comprise providing ultrasound energy from a ultrasound transducer; determining a voltage threshold of the ultrasound energy; monitoring a voltage of the ultrasound transducer over time; communicating the voltage to a controller; adjusting the frequency of the ultrasound energy upon an change in the voltage; monitoring a power level of the ultrasound energy over time of the ultrasound energy; communicating a power level to a controller; adjusting the frequency of the ultrasound energy upon a change in the power level; monitoring a temperature of the ultrasound transducer over time; communicating the temperature to a controller; adjusting the frequency of the ultrasound energy upon an change in the temperature; and maintaining the power level threshold of the ultrasound energy.
In some embodiments, the method can further comprise determining a temperature threshold of the ultrasound transducer and terminating the providing ultrasound energy when the temperature of the ultrasound transducer is above the temperature threshold.
In some embodiments, the method can further comprise emitting the ultrasound energy at a specific frequency and correcting the frequency to the specific frequency upon the change of voltage. In some embodiments, the method can comprise terminating the providing the ultrasound energy upon a change of the power level above the power level threshold.
In some embodiments, temperature can be monitored by monitoring changes in time of flight of the ultrasound energy from the transducer. In some embodiments, temperature can be monitored by a piezoelectric sensor that may be a portion of transducer, as described herein. In various embodiments, a controller may use a look up table to change a parameter. In some embodiments, controller can employ hardware, software, or a combination of both to change a parameter such as power, voltage or current.
With reference to
Ultrasound probe 205 may be individual hand-held device, or may be part of a treatment system or part of cosmetic enhancement system. The ultrasound probe 205 can provide both therapeutic ultrasound energy and imaging ultrasound energy. However, ultrasound probe 205 may provide only therapeutic ultrasound energy. Ultrasound probe 205 may comprise a therapeutic transducer and a separate imaging transducer. Ultrasound probe 205 may comprise a transducer or a transducer array capable of both therapeutic and imaging applications. According an alternative embodiment, ultrasound probe 205 is coupled directly to one of the tissue layers, as opposed to skin surface 204 to treat the tissue layer. For example, ultrasound probe 205 can be integrated to or attached to a tool, such as, for example, an arthroscopic tool, laparoscopic tool, or an endoscopic tool that may be inserted into a patient's body with minimal invasiveness.
In various embodiments, the ultrasound energy level is in a range of about 0.1 joules to about 500 joules in order to create an ablative lesion. However, the ultrasound energy 108 level can be in a range of from about 0.1 joules to about 100 joules, or from about 1 joules to about 50 joules, or from about 0.1 joules to about 10 joules, or from about 50 joules to about 100 joules, or from about 100 joules to about 500 joules, or from about 50 joules to about 250 joules.
Further, the amount of time ultrasound energy is applied at these levels varies in the range from approximately 1 millisecond to several minutes. However, a range can be from about 1 millisecond to about 5 minutes, or from about 1 millisecond to about 1 minute, or from about 1 millisecond to about 30 seconds, or from about 1 millisecond to about 10 seconds, or from about 1 millisecond to about 1 second, or from about millisecond to about 0.1 seconds, or about 0.1 seconds to about 10 seconds, or about 0.1 seconds to about 1 second, or from about 1 millisecond to about 200 milliseconds, or from about 1 millisecond to about 0.5 seconds.
The frequency of the ultrasound energy can be in a range from about 0.1 MHz to about 100 MHz, or from about 0.1 MHz to about 50 MHz, or from about 1 MHz to about 50 MHz or about 0.1 MHz to about 30 MHz, or from about 10 MHz to about 30 MHz, or from about 0.1 MHz to about 20 MHz, or from about 1 MHz to about 20 MHz, or from about 20 MHz to about 30 MHz.
The frequency of the ultrasound energy can be in a range from about 1 MHz to about 12 MHz, or from about 5 MHz to about 15 MHz, or from about 2 MHz to about 12 MHz or from about 3 MHz to about 7 MHz.
In some embodiments, the ultrasound energy can be transmitted to depths at or below a skin surface in a range from about 0 mm to about 150 mm, or from about 0 mm to about 100 mm, or from about 0 mm to about 50 mm, or from about 0 mm to about 30 mm, or from about 0 mm to about 20 mm, or from about 0 mm to about 10 mm, or from about 0 mm to about 5 mm. In some embodiments, the ultrasound energy can be transmitted to depths below a skin surface in a range from about 5 mm to about 150 mm, or from about 5 mm to about 100 mm, or from about 5 mm to about 50 mm, or from about 5 mm to about 30 mm, or from about 5 mm to about 20 mm, or from about 5 mm to about 10 mm. In some embodiments, the ultrasound energy can be transmitted to depths below a skin surface in a range from about 10 mm to about 150 mm, or from about 10 mm to about 100 mm, or from about 10 mm to about 50 mm, or from about 10 mm about 30 mm, or from about 10 mm to about 20 mm, or from about 0 mm to about 10 mm.
In some embodiments, the ultrasound energy can be transmitted to depths at or below a skin surface in the range from about 20 mm to about 150 mm, or from about 20 mm to about 100 mm, or from about 20 mm to about 50 mm, or from about 20 mm to about 30 mm. In some embodiments, the ultrasound energy can be transmitted to depths at below a skin surface in a range from about 30 mm to about 150 mm, or from about 30 mm to about 100 mm, or from about 30 mm to about 50 mm. In some embodiments, the ultrasound energy can be transmitted to depths at or below a skin surface in a range from about 50 mm to about 150 mm, or from about 50 mm to about 100 mm. In some embodiments, the ultrasound energy can be transmitted to depths at or below a skin surface in a range from about 20 mm to about 60 mm, or from about 40 mm to about 80 mm, or from about 10 mm to about 40 mm, or from about 5 mm to about 40 mm, or from about 0 mm to about 40 mm, or from about 10 mm to about 30 mm, or from about 5 mm to about 30 mm, or from about 0 mm to about 30 mm.
In various embodiments, a temperature of tissue receiving the ultrasound energy can be in a range from 30° C. to about 100° C., or from 43° C. to about 60° C., or from 50° C. to about 70° C., or from 30° C.; to about 50° C., or from 43° C. to about 100° C., or from 33° C. to about 100° C., or from 30° C. to about 65° C., or from 33° C. to about 70° C., as well as variations thereof.
Also, depending at least in part upon a specific biological effect and the tissue layers that are targeted, temperature of tissue receiving the ultrasound energy within ROI 215 may change in a range from approximately 10° C. to about 15° C. in various embodiments, a temperature of tissue receiving the ultrasound energy is raised to a temperature in a range from about 40° C. to about 55° C., or from about 43° C. to about 48° C., or below a threshold of ablation of the tissue.
Moving to
E=Pout/Pin Equation 1
If E % represents the efficiency as a percentage, then:
E %=100Pout/Pin Equation 2
In general, a transducer is not 100% efficient and power is typically lost during the operation of the transducer in the form of heat. However, for a high-Q transducer, efficiency can approach 100% and heat generated by the transducer is minimized. A transducer is most efficient at specific frequency fc, as illustrated in
When a transducer operates, the transducer heats up over time and the temperature of the transducer changes. As the temperature of the transducer changes, the resonant frequency will shift towards frequency ft, as illustrated in
Transducer efficiency decreases due to changes in temperature of the transducer as a function of time. In addition, a change in temperature of the transducer will cause a frequency shift. The frequency shift changes as a function of increasing temperature of the transducer. A frequency shift decreases efficiency and can cause a system to change total power input to make up for a loss of power applied by the transducer. A frequency shift will change the impedance of the transducer.
In various embodiments, systems and methods, described herein, monitor transducer temperature and report changes in temperature to a controller to modify the frequency generation to the transducer. In various embodiments, systems and methods can monitor transducer temperature and report changes in temperature to a controller to modify the total power input to the transducer. In various embodiments, systems and methods can monitor efficiency and controls transducer temperature to prevent energy transmission from a shift in frequency.
In various embodiments, systems and methods can at least one of monitor transducer temperature and control transducer temperature. In various embodiments, systems and methods can operate the transducer to at or near maximum efficiency of power over a period of time. In various embodiments, systems and methods can operate the transducer to at or near maximum efficiency of power as a temperature of the transducer changes. In various embodiments, systems and methods can modify temperature of the transducer to maintain operation at or near maximum efficiency of power. In various embodiments, systems and methods can prevent a change in impedance of the transducer.
In some embodiments, energy emission, such as, an ultrasound emission, can be directed to targeted tissue to initiate a desired treatment to the targeted tissue. If the power of the energy emission, such as, an ultrasound emission, is too high, the targeted tissue can be permanently damaged, which provide pain to the patient being treated. In addition, if the power of the energy emission such as, an ultrasound emission, is too high, the desired treatment to the targeted tissue may not be effective. If the power of the energy emission, such as, an ultrasound emission, is too low, the desired treatment to the targeted tissue may not be effective.
If the efficiency of the transducer degrades, the power of energy emission decreases. If the temperature of the transducer changes, the efficiency of the transducer changes and the power of energy emission decreases. For the most effective treatment to targeted tissue, power of energy emission is constant. Various embodiments provide methods and systems to provide constant energy emission from transducer 110 that is directed to targeted tissue.
Referring to
In some embodiments, power sensor 104 monitors power input from drivers 102 to transducer 110. In some embodiments, power sensor 104 communicates with controller 115, which controls oscillator 120. In some embodiments, controller 115 receives signal from power sensor 104 and controls a frequency generated by oscillator 120 based on the received signal. In some embodiments, power sensor 104 communicates a power level of the power input from drivers 102.
As transducer 110 efficiency of energy transmission 150 degrades, for example as illustrated in
In some embodiments, the thickness of the transduction element of transducer 110 may be configured to be uniform. That is, the transduction element may be configured to have a thickness that is generally substantially the same throughout. In another exemplary embodiment, the transduction element may also be configured with a variable thickness, and/or as a multiple damped device. For example, the transduction element of transducer 110 may be configured to have a first thickness selected to provide a specific operating frequency of a lower range, for example from approximately 1 kHz to 3 MHz. The transduction element may also be configured with a second thickness selected to provide a specific operating frequency of a higher range, for example from approximately 3 to 100 MHz or other frequency ranges described herein.
In yet another exemplary embodiment, transducer 110 may be configured as a single broadband transducer excited with two or more frequencies to provide an adequate output for raising the temperature within ROI 215 to the desired level. Transducer 110 may also be configured as two or more individual transducers, wherein each transducer 110 may comprise a transduction element. The thickness of the transduction elements may be configured to provide specific-operating frequencies in a desired treatment range. For example, in some embodiments, transducer 110 may comprise a first transducer 110 configured with a first transduction element having a thickness corresponding to a specific frequency range of approximately 1 MHz to 3 MHz, and a second transducer 110 configured with a second transduction element having a thickness corresponding to a specific frequency of approximately 3 MHz to 100 MHz or frequency ranges described herein.
Moreover, in some embodiments, any variety of mechanical lenses or variable focus lenses, e.g. liquid-filled lenses, may also be used to focus and or defocus the energy field. For example, transducer 110 may also be configured with an electronic focusing array in combination with one or more transduction elements to facilitate changed flexibility in treating ROI 215. Array may be configured in a manner similar to transducer 110. That is, array may be configured as an array of electronic apertures that may be operated by a variety of phases via variable electronic time delays. Accordingly, the electronic apertures of array may be manipulated, driven, used, configured to produce and/or deliver energy in a manner corresponding to the phase variation caused by the electronic time delay. For example, these phase variations may be used to deliver defocused beams, planar beams, and/or focused beams, each of which may be used in combination to achieve different physiological effects in ROI 215.
Transduction elements may be configured to be concave, convex, and/or planar. For example, transduction elements can be configured to be concave in order to provide focused energy for treatment of ROI 215. In another exemplary embodiment, transduction elements may be configured to be substantially flat in order to provide substantially uniform energy to ROI 215. In addition, transduction elements may be configured to be any combination of concave, convex, and/or substantially flat structures. For example, a first transduction element may be configured to be concave, while a second transduction element may be configured to be substantially flat.
Moreover, transduction element can be any distance from the skin surface 204. In that regard, it can be far away from the skin surface 204 disposed within a long transducer 110 or it can be just a few millimeters from skin surface 204. In certain exemplary embodiments, positioning the transduction element closer to skin surface 204 is better for transmitting ultrasound at high frequencies. Moreover, both two and three dimensional arrays of transduction elements can be used in various embodiments.
In some embodiments, transducer 110 may also be configured as an annular array to provide planar, focused and/or defocused acoustical energy. For example, in some embodiments, an annular array may comprise a plurality of rings. Rings may be mechanically and electrically isolated into a set of individual elements, and may create planar, focused, or defocused waves. For example, such waves can be specified on-axis, such as by methods of adjusting corresponding phase delays. An electronic focus may be moved along various depth positions in ROI 215, and may enable variable strength or beam tightness, while an electronic defocus may have varying amounts of defocusing. In some embodiments, a lens and/or convex or concave shaped annular array may also be provided to aid focusing or defocusing such that any time differential delays can be reduced. Movement of annular array in one, two or three-dimensions, or along any path, such as through use of probes, motion mechanisms, any conventional robotic arm mechanisms, and the like may be implemented to scan and/or treat a volume or any corresponding space within ROI 215.
In
Piezoelectric sensor 124 can comprise ceramic, or any other material or combination of material described herein. In some embodiments, piezoelectric sensor 124 is configured with a temperature coefficient that is lower than the temperature coefficient of transducer 110. In some embodiments, piezoelectric sensor 124 is configured with temperature coefficient, which is negative. In various embodiments, piezoelectric sensor 124 generates an electric potential in response to a temperature change, and communicates this electric potential to controller 115, which controls oscillator 120. In some embodiments, piezoelectric sensor 124 communicates with oscillator 120. In some embodiments, controller 115 receives signal from piezoelectric sensor 124 and controls a frequency generated by oscillator 120 based on the received signal. In some embodiments, piezoelectric sensor 124 communicates the heat generated by transducer 110, which can be communicated using temperature.
As transducer 110 efficiency of energy transmission 150 degrades, for example as illustrated in
Turning to
As transducer 110 efficiency of energy transmission 150 degrades, for example as illustrated in
Moving to
As transducer 110 efficiency of energy transmission 150 degrades, for example as illustrated in
As transducer 110 efficiency of energy transmission 150 degrades, for example as illustrated in
The following patents and patent applications are incorporated by reference: US Patent Application Publication No. 20050256406, entitled “Method and System for Controlled Scanning, Imaging, and/or Therapy” published Nov. 17, 2005; US Patent Application Publication No. 20060058664, entitled “System and Method for Variable Depth Ultrasound Treatment” published Mar. 16, 2006; US Patent Application Publication No. 20060084891, entitled “Method and System for Ultra-High Frequency Ultrasound Treatment” published Apr. 20, 2006; U.S. Pat. No. 7,530,958, entitled “Method and System for Combined Ultrasound Treatment” issued May 12, 2009; US Patent Application Publication No. 2008071255, entitled “Method and System for Treating Muscle, Tendon, Ligament, and Cartilage Tissue” published Mar. 20, 2008; U.S. Pat. No. 6,623,430, entitled “Method and Apparatus for Safely Delivering Medicants to a Region of Tissue Using Imaging, Therapy, and Temperature Monitoring Ultrasonic System,” issued Sep. 23, 2003; U.S. Pat. No. 7,571,336, entitled “Method and System for Enhancing Safety with Medical Peripheral Device by Monitoring if Host Computer is AC Powered” issued Aug. 4, 2009; US Patent Application Publication No. 20080281255, entitled “Methods and Systems for Modulating Medicants Using Acoustic Energy” published Nov. 13, 2008; US Patent Application Publication No. 20060116671, entitled “Method and System for Controlled Thermal Injury of Human Superficial Tissue,” published Jun. 1, 2006; US Patent Application Publication No. 20060111744, entitled “Method and System for Treatment of Sweat Glands,” published May 25, 2006; US Patent Application Publication No. 20080294073, entitled “Method and System for Non-Ablative Acne Treatment and Prevention,” published Oct. 8, 2009; U.S. Pat. No. 8,133,180, entitled “Method and System for Treating Cellulite,” issued Mar. 13, 2012; U.S. Pat. No. 8,066,641, entitled “Method and System for Photoaged Tissue,” issued Nov. 29, 2011; U.S. Pat. No. 7,491,171, entitled “Method and System for Treating. Acne and Sebaceous Glands,” issued Feb. 17, 2009; U.S. Pat. No. 7,615,016, entitled “Method and System for Treating Stretch Marks,” issued Nov. 10, 2009; and U.S. Pat. No. 7,530,356, entitled “Method and System for Noninvasive Mastopexy,” issued May 12, 2009.
It is believed that the disclosure set forth above encompasses at least one distinct invention with independent utility. While the invention has been disclosed herein, the specific embodiments thereof as disclosed and illustrated herein are not to be considered in a limiting sense as numerous variations are possible. The subject matter of the inventions includes all novel and non-obvious combinations and sub combinations of the various elements, features, functions and/or properties disclosed herein.
Various embodiments and the examples described herein are not intended to be limiting in describing the full scope of systems and methods of this invention. Equivalent changes, modifications and variations of various embodiments, materials, systems, and methods may be made within the scope of the present invention, with substantially similar results.
This application claims priority to and the benefit of U.S. Provisional Patent Application Ser. No. 61/506,609, entitled “Systems and Methods for Monitoring Ultrasound Power Efficiency,” filed Jul. 11, 2011; and U.S. Provisional Patent Application Ser. No. 61/506,610, entitled “Methods and Systems for Controlling Acoustic Energy Deposition into a Medium,” filed Jul. 11, 2011; all of which are incorporated by reference herein.
Number | Name | Date | Kind |
---|---|---|---|
2427348 | Bond et al. | Sep 1947 | A |
3913386 | Saglio | Oct 1975 | A |
3965455 | Hurwitz | Jun 1976 | A |
3992925 | Perilhou | Nov 1976 | A |
4039312 | Patru | Aug 1977 | A |
4059098 | Murdock | Nov 1977 | A |
4101795 | Fukumoto | Jul 1978 | A |
4166967 | Benes et al. | Sep 1979 | A |
4211948 | Brisken et al. | Jul 1980 | A |
4211949 | Brisken et al. | Jul 1980 | A |
4213344 | Rose | Jul 1980 | A |
4276491 | Daniel | Jun 1981 | A |
4315514 | Drewes et al. | Feb 1982 | A |
4325381 | Glenn | Apr 1982 | A |
4343301 | Indech | Aug 1982 | A |
4372296 | Fahim | Feb 1983 | A |
4379145 | Masuho et al. | Apr 1983 | A |
4381007 | Doss | Apr 1983 | A |
4381787 | Hottinger | May 1983 | A |
4397314 | Vaguine | Aug 1983 | A |
4409839 | Taenzer | Oct 1983 | A |
4431008 | Wanner et al. | Feb 1984 | A |
4441486 | Pounds | Apr 1984 | A |
4452084 | Taenzer | Jun 1984 | A |
4484569 | Driller et al. | Nov 1984 | A |
4507582 | Glenn | Mar 1985 | A |
4513749 | Kino et al. | Apr 1985 | A |
4513750 | Heyman et al. | Apr 1985 | A |
4527550 | Ruggera et al. | Jul 1985 | A |
4528979 | Marchenko et al. | Jul 1985 | A |
4534221 | Fife et al. | Aug 1985 | A |
4566459 | Umemura et al. | Jan 1986 | A |
4567895 | Putzke | Feb 1986 | A |
4586512 | Do-huu | May 1986 | A |
4601296 | Yerushalmi | Jul 1986 | A |
4620546 | Aida et al. | Nov 1986 | A |
4637256 | Sugiyama et al. | Jan 1987 | A |
4646756 | Watmough | Mar 1987 | A |
4663358 | Hyon | May 1987 | A |
4668516 | Duraffourd et al. | May 1987 | A |
4672591 | Breimesser et al. | Jun 1987 | A |
4680499 | Umemura et al. | Jul 1987 | A |
4697588 | Reichenberger | Oct 1987 | A |
4754760 | Fukukita et al. | Jul 1988 | A |
4757820 | Itoh | Jul 1988 | A |
4771205 | Mequio | Sep 1988 | A |
4801459 | Liburdy | Jan 1989 | A |
4803625 | Fu et al. | Feb 1989 | A |
4807633 | Fry | Feb 1989 | A |
4817615 | Fukukita et al. | Apr 1989 | A |
4858613 | Fry | Aug 1989 | A |
4860732 | Hasegawa et al. | Aug 1989 | A |
4865041 | Hassler | Sep 1989 | A |
4865042 | Umemura | Sep 1989 | A |
4867169 | Machida | Sep 1989 | A |
4874562 | Hyon | Oct 1989 | A |
4875487 | Seppi | Oct 1989 | A |
4891043 | Zeimer et al. | Jan 1990 | A |
4893624 | Lele | Jan 1990 | A |
4896673 | Rose | Jan 1990 | A |
4900540 | Ryan et al. | Feb 1990 | A |
4901729 | Saitoh et al. | Feb 1990 | A |
D306965 | Jaworski | Apr 1990 | S |
4917096 | Englehart | Apr 1990 | A |
4932414 | Coleman et al. | Jun 1990 | A |
4938216 | Lele | Jul 1990 | A |
4938217 | Lele | Jul 1990 | A |
4947046 | Kawabata et al. | Aug 1990 | A |
4951653 | Fry | Aug 1990 | A |
4955365 | Fry | Sep 1990 | A |
4958626 | Nambu | Sep 1990 | A |
4976709 | Sand | Dec 1990 | A |
4979501 | Valchanov | Dec 1990 | A |
4992989 | Watanabe et al. | Feb 1991 | A |
5012797 | Liang | May 1991 | A |
5018508 | Fry et al. | May 1991 | A |
5030874 | Saito et al. | Jul 1991 | A |
5036855 | Fry | Aug 1991 | A |
5040537 | Katakura | Aug 1991 | A |
5054310 | Flynn | Oct 1991 | A |
5054470 | Fry | Oct 1991 | A |
5070879 | Herres | Dec 1991 | A |
5088495 | Miyagawa | Feb 1992 | A |
5115814 | Griffith | May 1992 | A |
5117832 | Sanghvi | Jun 1992 | A |
5123418 | Saurel | Jun 1992 | A |
5143063 | Fellner | Sep 1992 | A |
5143074 | Dory | Sep 1992 | A |
5149319 | Unger | Sep 1992 | A |
5150711 | Dory | Sep 1992 | A |
5150714 | Green | Sep 1992 | A |
5152294 | Mochizuki et al. | Oct 1992 | A |
5156144 | Iwasaki | Oct 1992 | A |
5158536 | Sekins | Oct 1992 | A |
5159931 | Pini | Nov 1992 | A |
5163421 | Bernstein | Nov 1992 | A |
5163436 | Saitoh et al. | Nov 1992 | A |
5178135 | Uchiyama et al. | Jan 1993 | A |
5190518 | Takasu | Mar 1993 | A |
5190766 | Ishihara | Mar 1993 | A |
5191880 | McLeod | Mar 1993 | A |
5205287 | Erbel et al. | Apr 1993 | A |
5209720 | Unger | May 1993 | A |
5212671 | Fujii et al. | May 1993 | A |
5215680 | D Arrigo | Jun 1993 | A |
5224467 | Oku | Jul 1993 | A |
5230334 | Klopotek | Jul 1993 | A |
5230338 | Allen et al. | Jul 1993 | A |
5247924 | Suzuki et al. | Sep 1993 | A |
5255681 | Ishimura et al. | Oct 1993 | A |
5257970 | Dougherty | Nov 1993 | A |
5265614 | Hayakawa | Nov 1993 | A |
5267985 | Shimada et al. | Dec 1993 | A |
5269297 | Weng | Dec 1993 | A |
5282797 | Chess | Feb 1994 | A |
5295484 | Marcus | Mar 1994 | A |
5295486 | Wollschlager et al. | Mar 1994 | A |
5304169 | Sand | Apr 1994 | A |
5305756 | Entrekin et al. | Apr 1994 | A |
5321520 | Inga et al. | Jun 1994 | A |
5323779 | Hardy et al. | Jun 1994 | A |
5327895 | Hashimoto et al. | Jul 1994 | A |
5348016 | Unger et al. | Sep 1994 | A |
5360268 | Hayashi | Nov 1994 | A |
5370121 | Reichenberger | Dec 1994 | A |
5371483 | Bhardwaj | Dec 1994 | A |
5375602 | Lancee et al. | Dec 1994 | A |
5379773 | Hornsby | Jan 1995 | A |
5380280 | Peterson | Jan 1995 | A |
5380519 | Schneider et al. | Jan 1995 | A |
5383917 | Desai et al. | Jan 1995 | A |
5391140 | Schaetzle | Feb 1995 | A |
5391197 | Burdette et al. | Feb 1995 | A |
5392259 | Bolorforosh | Feb 1995 | A |
5396143 | Seyed-Bolorforosh et al. | Mar 1995 | A |
5398689 | Connor et al. | Mar 1995 | A |
5406503 | Williams, Jr. et al. | Apr 1995 | A |
5417216 | Tanaka | May 1995 | A |
5419327 | Rohwedder | May 1995 | A |
5423220 | Finsterwald et al. | Jun 1995 | A |
5435311 | Umemura | Jul 1995 | A |
5438998 | Hanafy | Aug 1995 | A |
5458596 | Lax | Oct 1995 | A |
5460179 | Okunuki et al. | Oct 1995 | A |
5460595 | Hall et al. | Oct 1995 | A |
5469854 | Unger et al. | Nov 1995 | A |
5471988 | Fujio | Dec 1995 | A |
5487388 | Rello et al. | Jan 1996 | A |
5492126 | Hennige | Feb 1996 | A |
5496256 | Bock | Mar 1996 | A |
5501655 | Rolt | Mar 1996 | A |
5503152 | Oakley et al. | Apr 1996 | A |
5503320 | Webster et al. | Apr 1996 | A |
5507790 | Weiss | Apr 1996 | A |
5520188 | Hennige | May 1996 | A |
5522869 | Burdette | Jun 1996 | A |
5523058 | Umemura et al. | Jun 1996 | A |
5524620 | Rosenschein | Jun 1996 | A |
5524624 | Tepper | Jun 1996 | A |
5524625 | Okazaki et al. | Jun 1996 | A |
5526624 | Berg | Jun 1996 | A |
5526812 | Dumoulin et al. | Jun 1996 | A |
5526814 | Cline et al. | Jun 1996 | A |
5526815 | Granz | Jun 1996 | A |
5529070 | Augustine et al. | Jun 1996 | A |
5540235 | Wilson | Jul 1996 | A |
5558092 | Unger | Sep 1996 | A |
5560362 | Sliwa et al. | Oct 1996 | A |
5575291 | Hayakawa | Nov 1996 | A |
5575807 | Faller | Nov 1996 | A |
5577502 | Darrow et al. | Nov 1996 | A |
5577507 | Snyder et al. | Nov 1996 | A |
5577991 | Akui et al. | Nov 1996 | A |
5580575 | Unger et al. | Dec 1996 | A |
5601526 | Chapelon | Feb 1997 | A |
5603323 | Pflugrath et al. | Feb 1997 | A |
5609562 | Kaali | Mar 1997 | A |
5615091 | Palatnik | Mar 1997 | A |
5617858 | Taverna et al. | Apr 1997 | A |
5618275 | Bock | Apr 1997 | A |
5620479 | Diederich | Apr 1997 | A |
5622175 | Sudol et al. | Apr 1997 | A |
5638819 | Manwaring et al. | Jun 1997 | A |
5643179 | Fujimoto | Jul 1997 | A |
5644085 | Lorraine et al. | Jul 1997 | A |
5647373 | Paltieli | Jul 1997 | A |
5655535 | Friemel et al. | Aug 1997 | A |
5655538 | Lorraine | Aug 1997 | A |
5657760 | Ying | Aug 1997 | A |
5658328 | Johnson | Aug 1997 | A |
5660836 | Knowlton | Aug 1997 | A |
5662116 | Kondo et al. | Sep 1997 | A |
5665053 | Jacobs | Sep 1997 | A |
5665141 | Vago | Sep 1997 | A |
5671746 | Dreschel et al. | Sep 1997 | A |
5673699 | Trahey et al. | Oct 1997 | A |
5676692 | Sanghvi | Oct 1997 | A |
5685820 | Riek et al. | Nov 1997 | A |
5687737 | Branham et al. | Nov 1997 | A |
5690608 | Watanabe | Nov 1997 | A |
5694936 | Fujimoto | Dec 1997 | A |
5697897 | Buchholtz | Dec 1997 | A |
5701900 | Shehada et al. | Dec 1997 | A |
5704361 | Seward et al. | Jan 1998 | A |
5706252 | Le Verrier et al. | Jan 1998 | A |
5706564 | Rhyne | Jan 1998 | A |
5715823 | Wood et al. | Feb 1998 | A |
5720287 | Chapelon et al. | Feb 1998 | A |
5722411 | Suzuki | Mar 1998 | A |
5727554 | Kalend et al. | Mar 1998 | A |
5735280 | Sherman et al. | Apr 1998 | A |
5743863 | Chapelon | Apr 1998 | A |
5746005 | Steinberg | May 1998 | A |
5746762 | Bass | May 1998 | A |
5748767 | Raab | May 1998 | A |
5749364 | Sliwa et al. | May 1998 | A |
5755228 | Wilson et al. | May 1998 | A |
5755753 | Knowlton | May 1998 | A |
5762066 | Law | Jun 1998 | A |
5763886 | Schulte | Jun 1998 | A |
5769790 | Watkins | Jun 1998 | A |
5779644 | Eberle et al. | Jul 1998 | A |
5792058 | Lee et al. | Aug 1998 | A |
5795297 | Daigle | Aug 1998 | A |
5795311 | Wess | Aug 1998 | A |
5810009 | Mine et al. | Sep 1998 | A |
5810888 | Fenn | Sep 1998 | A |
5814599 | Mitragotri et al. | Sep 1998 | A |
5817013 | Ginn et al. | Oct 1998 | A |
5817021 | Reichenberger | Oct 1998 | A |
5820564 | Slayton | Oct 1998 | A |
5823962 | Schaetzle | Oct 1998 | A |
5827204 | Grandia et al. | Oct 1998 | A |
5839751 | Lutz | Nov 1998 | A |
5840032 | Hatfield et al. | Nov 1998 | A |
5844140 | Seale | Dec 1998 | A |
5853367 | Chalek et al. | Dec 1998 | A |
5869751 | Bonin | Feb 1999 | A |
5871524 | Knowlton | Feb 1999 | A |
5873902 | Sanghvi | Feb 1999 | A |
5876431 | Spehr et al. | Mar 1999 | A |
5879303 | Averkiou et al. | Mar 1999 | A |
5882557 | Hayakawa | Mar 1999 | A |
5891034 | Bucholz | Apr 1999 | A |
5899861 | Friemel et al. | May 1999 | A |
5904659 | Duarte | May 1999 | A |
5919219 | Knowlton | Jul 1999 | A |
5923099 | Bilir | Jul 1999 | A |
5924989 | Polz | Jul 1999 | A |
5928169 | Schatzle et al. | Jul 1999 | A |
5931805 | Brisken | Aug 1999 | A |
5938606 | Bonnefous | Aug 1999 | A |
5938612 | Kline-Schoder | Aug 1999 | A |
5948011 | Knowlton | Sep 1999 | A |
5957844 | Dekel | Sep 1999 | A |
5957882 | Nita et al. | Sep 1999 | A |
5957941 | Ream | Sep 1999 | A |
5967980 | Ferre et al. | Oct 1999 | A |
5968034 | Fullmer | Oct 1999 | A |
5971949 | Levin | Oct 1999 | A |
5977538 | Unger et al. | Nov 1999 | A |
5984882 | Rosenschein | Nov 1999 | A |
5990598 | Sudol et al. | Nov 1999 | A |
5997471 | Gumb et al. | Dec 1999 | A |
5997497 | Nita et al. | Dec 1999 | A |
5999843 | Anbar | Dec 1999 | A |
6004262 | Putz et al. | Dec 1999 | A |
6007499 | Martin et al. | Dec 1999 | A |
6013032 | Savord | Jan 2000 | A |
6016255 | Bolan et al. | Jan 2000 | A |
6019724 | Gronningsaeter et al. | Feb 2000 | A |
6022308 | Williams | Feb 2000 | A |
6022327 | Chang | Feb 2000 | A |
6036646 | Barthe | Mar 2000 | A |
6039048 | Silberg | Mar 2000 | A |
6039689 | Lizzi | Mar 2000 | A |
6042556 | Beach et al. | Mar 2000 | A |
6049159 | Barthe | Apr 2000 | A |
6050943 | Slayton | Apr 2000 | A |
6059727 | Fowlkes | May 2000 | A |
6071239 | Cribbs | Jun 2000 | A |
6080108 | Dunham | Jun 2000 | A |
6083148 | Williams | Jul 2000 | A |
6086535 | Ishibashi | Jul 2000 | A |
6086580 | Mordon et al. | Jul 2000 | A |
6090054 | Tagishi | Jul 2000 | A |
6093883 | Sanghvi | Jul 2000 | A |
6101407 | Groezinger | Aug 2000 | A |
6106469 | Suzuki et al. | Aug 2000 | A |
6113558 | Rosenschein | Sep 2000 | A |
6113559 | Klopotek | Sep 2000 | A |
6120452 | Barthe | Sep 2000 | A |
6123081 | Durette | Sep 2000 | A |
6126619 | Peterson et al. | Oct 2000 | A |
6135971 | Hutchinson et al. | Oct 2000 | A |
6139499 | Wilk | Oct 2000 | A |
6159150 | Yale et al. | Dec 2000 | A |
6171244 | Finger et al. | Jan 2001 | B1 |
6176840 | Nishimura | Jan 2001 | B1 |
6183426 | Akisada | Feb 2001 | B1 |
6183502 | Takeuchi | Feb 2001 | B1 |
6183773 | Anderson | Feb 2001 | B1 |
6190323 | Dias et al. | Feb 2001 | B1 |
6190336 | Duarte | Feb 2001 | B1 |
6193658 | Wendelken et al. | Feb 2001 | B1 |
6210327 | Brackett et al. | Apr 2001 | B1 |
6213948 | Barthe | Apr 2001 | B1 |
6216029 | Paltieli | Apr 2001 | B1 |
6233476 | Strommer et al. | May 2001 | B1 |
6234990 | Rowe et al. | May 2001 | B1 |
6241753 | Knowlton | Jun 2001 | B1 |
6246898 | Vesely et al. | Jun 2001 | B1 |
6251074 | Averkiou et al. | Jun 2001 | B1 |
6251088 | Kaufman et al. | Jun 2001 | B1 |
6268405 | Yao | Jul 2001 | B1 |
6273864 | Duarte | Aug 2001 | B1 |
6280402 | Ishibashi et al. | Aug 2001 | B1 |
6287257 | Matichuk | Sep 2001 | B1 |
6296619 | Brisken | Oct 2001 | B1 |
6301989 | Brown et al. | Oct 2001 | B1 |
6309355 | Cain et al. | Oct 2001 | B1 |
6311090 | Knowlton | Oct 2001 | B1 |
6315741 | Martin | Nov 2001 | B1 |
6322509 | Pan et al. | Nov 2001 | B1 |
6322532 | D'Sa | Nov 2001 | B1 |
6325540 | Lounsberry et al. | Dec 2001 | B1 |
6325758 | Carol et al. | Dec 2001 | B1 |
6325769 | Klopotek | Dec 2001 | B1 |
6325798 | Edwards et al. | Dec 2001 | B1 |
6338716 | Hossack et al. | Jan 2002 | B1 |
6350276 | Knowlton | Feb 2002 | B1 |
6356780 | Licato et al. | Mar 2002 | B1 |
6361531 | Hissong | Mar 2002 | B1 |
6370411 | Osadchy et al. | Apr 2002 | B1 |
6375672 | Aksan | Apr 2002 | B1 |
6377854 | Knowlton | Apr 2002 | B1 |
6377855 | Knowlton | Apr 2002 | B1 |
6381497 | Knowlton | Apr 2002 | B1 |
6381498 | Knowlton | Apr 2002 | B1 |
6387380 | Knowlton | May 2002 | B1 |
6390982 | Bova et al. | May 2002 | B1 |
6405090 | Knowlton | Jun 2002 | B1 |
6409720 | Hissong | Jun 2002 | B1 |
6413216 | Cain et al. | Jul 2002 | B1 |
6413253 | Koop | Jul 2002 | B1 |
6413254 | Hissong | Jul 2002 | B1 |
6419648 | Vitek | Jul 2002 | B1 |
6423007 | Lizzi et al. | Jul 2002 | B2 |
6425865 | Salcudean | Jul 2002 | B1 |
6425867 | Vaezy | Jul 2002 | B1 |
6425912 | Knowlton | Jul 2002 | B1 |
6428477 | Mason | Aug 2002 | B1 |
6428532 | Doukas | Aug 2002 | B1 |
6430446 | Knowlton | Aug 2002 | B1 |
6432057 | Mazess et al. | Aug 2002 | B1 |
6432067 | Martin | Aug 2002 | B1 |
6432101 | Weber | Aug 2002 | B1 |
6436061 | Costantino | Aug 2002 | B1 |
6438424 | Knowlton | Aug 2002 | B1 |
6440071 | Slayton | Aug 2002 | B1 |
6440121 | Weber | Aug 2002 | B1 |
6443914 | Costantino | Sep 2002 | B1 |
6453202 | Knowlton | Sep 2002 | B1 |
6461378 | Knowlton | Oct 2002 | B1 |
6470216 | Knowlton | Oct 2002 | B1 |
6488626 | Lizzi et al. | Dec 2002 | B1 |
6491657 | Rowe | Dec 2002 | B2 |
6500121 | Slayton | Dec 2002 | B1 |
6500141 | Irion | Dec 2002 | B1 |
6508774 | Acker | Jan 2003 | B1 |
6511427 | Sliwa, Jr. et al. | Jan 2003 | B1 |
6511428 | Azuma | Jan 2003 | B1 |
6514244 | Pope | Feb 2003 | B2 |
6517484 | Wilk et al. | Feb 2003 | B1 |
6524250 | Weber | Feb 2003 | B1 |
6540679 | Slayton | Apr 2003 | B2 |
6540685 | Rhoads et al. | Apr 2003 | B1 |
6540700 | Fujimoto et al. | Apr 2003 | B1 |
6554771 | Buil et al. | Apr 2003 | B1 |
6569099 | Babaev | May 2003 | B1 |
6569108 | Sarvazyan et al. | May 2003 | B2 |
6572552 | Fukukita | Jun 2003 | B2 |
6575956 | Brisken et al. | Jun 2003 | B1 |
6595934 | Hissong | Jul 2003 | B1 |
6599256 | Acker | Jul 2003 | B1 |
6607498 | Eshel | Aug 2003 | B2 |
6618620 | Freundlich et al. | Sep 2003 | B1 |
6623430 | Slayton | Sep 2003 | B1 |
6626854 | Friedman | Sep 2003 | B2 |
6626855 | Weng | Sep 2003 | B1 |
6638226 | He et al. | Oct 2003 | B2 |
6645162 | Friedman | Nov 2003 | B2 |
6662054 | Kreindel | Dec 2003 | B2 |
6663627 | Francischelli | Dec 2003 | B2 |
6665806 | Shimizu | Dec 2003 | B1 |
6666835 | Martin | Dec 2003 | B2 |
6669638 | Miller et al. | Dec 2003 | B1 |
6685640 | Fry | Feb 2004 | B1 |
6692450 | Coleman | Feb 2004 | B1 |
6699237 | Weber | Mar 2004 | B2 |
6716184 | Vaezy et al. | Apr 2004 | B2 |
6719449 | Laugharn | Apr 2004 | B1 |
6719694 | Weng | Apr 2004 | B2 |
6726627 | Lizzi et al. | Apr 2004 | B1 |
6733449 | Krishnamurthy et al. | May 2004 | B1 |
6749624 | Knowlton | Jun 2004 | B2 |
6773409 | Truckai et al. | Aug 2004 | B2 |
6775404 | Pagoulatos et al. | Aug 2004 | B1 |
6790187 | Thompson et al. | Sep 2004 | B2 |
6824516 | Batten et al. | Nov 2004 | B2 |
6825176 | White et al. | Nov 2004 | B2 |
6835940 | Morikawa et al. | Dec 2004 | B2 |
6846290 | Lizzi et al. | Jan 2005 | B2 |
6875176 | Mourad et al. | Apr 2005 | B2 |
6882884 | Mosk et al. | Apr 2005 | B1 |
6887239 | Elstrom | May 2005 | B2 |
6889089 | Behl | May 2005 | B2 |
6896657 | Willis | May 2005 | B2 |
6902536 | Manna | Jun 2005 | B2 |
6905466 | Salgo | Jun 2005 | B2 |
6918907 | Kelly | Jul 2005 | B2 |
6920883 | Bessette | Jul 2005 | B2 |
6921371 | Wilson | Jul 2005 | B2 |
6932771 | Whitmore | Aug 2005 | B2 |
6932814 | Wood | Aug 2005 | B2 |
6936044 | McDaniel | Aug 2005 | B2 |
6936046 | Hissong | Aug 2005 | B2 |
6945937 | Culp et al. | Sep 2005 | B2 |
6948843 | Laugharn et al. | Sep 2005 | B2 |
6953941 | Nakano et al. | Oct 2005 | B2 |
6958043 | Hissong | Oct 2005 | B2 |
6971994 | Young et al. | Dec 2005 | B1 |
6974417 | Lockwood | Dec 2005 | B2 |
6976492 | Ingle | Dec 2005 | B2 |
6992305 | Maezawa et al. | Jan 2006 | B2 |
6997923 | Anderson | Feb 2006 | B2 |
7006874 | Knowlton | Feb 2006 | B2 |
7020528 | Neev | Mar 2006 | B2 |
7022089 | Ooba | Apr 2006 | B2 |
7058440 | Heuscher et al. | Jun 2006 | B2 |
7063666 | Weng | Jun 2006 | B2 |
7070565 | Vaezy et al. | Jul 2006 | B2 |
7074218 | Washington et al. | Jul 2006 | B2 |
7094252 | Koop | Aug 2006 | B2 |
7108663 | Talish et al. | Sep 2006 | B2 |
7115123 | Knowlton | Oct 2006 | B2 |
7122029 | Koop et al. | Oct 2006 | B2 |
7142905 | Slayton | Nov 2006 | B2 |
7165451 | Brooks et al. | Jan 2007 | B1 |
7179238 | Hissong | Feb 2007 | B2 |
7189230 | Knowlton | Mar 2007 | B2 |
7229411 | Slayton | Jun 2007 | B2 |
7235592 | Muratoglu | Jun 2007 | B2 |
7258674 | Cribbs | Aug 2007 | B2 |
7273459 | Desilets | Sep 2007 | B2 |
7294125 | Phalen et al. | Nov 2007 | B2 |
7297117 | Trucco et al. | Nov 2007 | B2 |
7303555 | Makin et al. | Dec 2007 | B2 |
7327071 | Nishiyama et al. | Feb 2008 | B2 |
7331951 | Eshel et al. | Feb 2008 | B2 |
7332985 | Larson, III et al. | Feb 2008 | B2 |
7347855 | Eshel | Mar 2008 | B2 |
RE40403 | Cho et al. | Jun 2008 | E |
7393325 | Barthe | Jul 2008 | B2 |
7398116 | Edwards | Jul 2008 | B2 |
7399279 | Abend et al. | Jul 2008 | B2 |
7491171 | Barthe et al. | Feb 2009 | B2 |
7510536 | Foley et al. | Mar 2009 | B2 |
7530356 | Slayton | May 2009 | B2 |
7530958 | Slayton | May 2009 | B2 |
7571336 | Barthe | Aug 2009 | B2 |
7601120 | Moilanen et al. | Oct 2009 | B2 |
7615015 | Coleman | Nov 2009 | B2 |
7615016 | Barthe | Nov 2009 | B2 |
7686763 | Vaezy et al. | Mar 2010 | B2 |
7695437 | Quistgaard et al. | Apr 2010 | B2 |
7758524 | Barthe | Jul 2010 | B2 |
7789841 | Huckle et al. | Sep 2010 | B2 |
7824348 | Barthe et al. | Nov 2010 | B2 |
7846096 | Mast et al. | Dec 2010 | B2 |
7857773 | Desilets et al. | Dec 2010 | B2 |
7875023 | Eshel et al. | Jan 2011 | B2 |
7914453 | Slayton et al. | Mar 2011 | B2 |
7914469 | Torbati | Mar 2011 | B2 |
7931611 | Novak et al. | Apr 2011 | B2 |
7955281 | Pedersen et al. | Jun 2011 | B2 |
7967764 | Lidgren et al. | Jun 2011 | B2 |
7967839 | Flock et al. | Jun 2011 | B2 |
8057389 | Barthe et al. | Nov 2011 | B2 |
8057465 | Sliwa, Jr. et al. | Nov 2011 | B2 |
8066641 | Barthe et al. | Nov 2011 | B2 |
8123707 | Huckle et al. | Feb 2012 | B2 |
8128618 | Gliklich et al. | Mar 2012 | B2 |
8133180 | Slayton et al. | Mar 2012 | B2 |
8133191 | Rosenberg et al. | Mar 2012 | B2 |
8166332 | Barthe et al. | Apr 2012 | B2 |
8197409 | Foley et al. | Jun 2012 | B2 |
8206299 | Foley et al. | Jun 2012 | B2 |
8211017 | Foley et al. | Jul 2012 | B2 |
8262591 | Pedersen et al. | Sep 2012 | B2 |
8273037 | Kreindel et al. | Sep 2012 | B2 |
8282554 | Makin et al. | Oct 2012 | B2 |
8333700 | Barthe et al. | Dec 2012 | B1 |
8366622 | Slayton et al. | Feb 2013 | B2 |
8409097 | Slayton et al. | Apr 2013 | B2 |
8444562 | Barthe et al. | May 2013 | B2 |
8480585 | Slayton et al. | Jul 2013 | B2 |
8506486 | Slayton et al. | Aug 2013 | B2 |
8523775 | Barthe et al. | Sep 2013 | B2 |
8535228 | Slayton et al. | Sep 2013 | B2 |
8585618 | Hunziker et al. | Nov 2013 | B2 |
8636665 | Slayton et al. | Jan 2014 | B2 |
8641622 | Barthe et al. | Feb 2014 | B2 |
8663112 | Slayton et al. | Mar 2014 | B2 |
8672848 | Slayton et al. | Mar 2014 | B2 |
8690778 | Slayton et al. | Apr 2014 | B2 |
8690779 | Slayton et al. | Apr 2014 | B2 |
8690780 | Slayton et al. | Apr 2014 | B2 |
8708935 | Barthe et al. | Apr 2014 | B2 |
8715186 | Slayton et al. | May 2014 | B2 |
8726781 | Eckhoff et al. | May 2014 | B2 |
20010009997 | Pope | Jul 2001 | A1 |
20010009999 | Kaufman et al. | Jul 2001 | A1 |
20010014780 | Martin et al. | Aug 2001 | A1 |
20010014819 | Ingle et al. | Aug 2001 | A1 |
20010031922 | Weng et al. | Oct 2001 | A1 |
20010039380 | Larson et al. | Nov 2001 | A1 |
20010041880 | Brisken | Nov 2001 | A1 |
20020000763 | Jones | Jan 2002 | A1 |
20020002345 | Marlinghaus | Jan 2002 | A1 |
20020040199 | Klopotek | Apr 2002 | A1 |
20020040442 | Ishidera | Apr 2002 | A1 |
20020052550 | Madsen et al. | May 2002 | A1 |
20020055702 | Atala | May 2002 | A1 |
20020062077 | Emmenegger et al. | May 2002 | A1 |
20020062142 | Knowlton | May 2002 | A1 |
20020072691 | Thompson et al. | Jun 2002 | A1 |
20020082528 | Friedman et al. | Jun 2002 | A1 |
20020082529 | Suorsa et al. | Jun 2002 | A1 |
20020082589 | Friedman et al. | Jun 2002 | A1 |
20020087080 | Slayton et al. | Jul 2002 | A1 |
20020095143 | Key | Jul 2002 | A1 |
20020099094 | Anderson | Jul 2002 | A1 |
20020115917 | Honda et al. | Aug 2002 | A1 |
20020128648 | Weber | Sep 2002 | A1 |
20020143252 | Dunne et al. | Oct 2002 | A1 |
20020156400 | Babaev | Oct 2002 | A1 |
20020161357 | Anderson | Oct 2002 | A1 |
20020165529 | Danek | Nov 2002 | A1 |
20020168049 | Schriever | Nov 2002 | A1 |
20020169394 | Eppstein et al. | Nov 2002 | A1 |
20020169442 | Neev | Nov 2002 | A1 |
20020173721 | Grunwald et al. | Nov 2002 | A1 |
20020193784 | McHale et al. | Dec 2002 | A1 |
20020193831 | Smith | Dec 2002 | A1 |
20030009153 | Brisken et al. | Jan 2003 | A1 |
20030014039 | Barzell et al. | Jan 2003 | A1 |
20030018255 | Martin | Jan 2003 | A1 |
20030028111 | Vaezy et al. | Feb 2003 | A1 |
20030028113 | Gilbert et al. | Feb 2003 | A1 |
20030032900 | Ella | Feb 2003 | A1 |
20030036706 | Slayton et al. | Feb 2003 | A1 |
20030040442 | Yokouchi | Feb 2003 | A1 |
20030040739 | Koop | Feb 2003 | A1 |
20030050678 | Sierra | Mar 2003 | A1 |
20030055417 | Truckai et al. | Mar 2003 | A1 |
20030060736 | Martin et al. | Mar 2003 | A1 |
20030065313 | Koop | Apr 2003 | A1 |
20030074023 | Kaplan | Apr 2003 | A1 |
20030083536 | Eshel | May 2003 | A1 |
20030092988 | Makin | May 2003 | A1 |
20030097071 | Halmann et al. | May 2003 | A1 |
20030099383 | Lefebvre | May 2003 | A1 |
20030125629 | Ustuner | Jul 2003 | A1 |
20030139790 | Ingle et al. | Jul 2003 | A1 |
20030171678 | Batten et al. | Sep 2003 | A1 |
20030171701 | Babaev | Sep 2003 | A1 |
20030176790 | Slayton | Sep 2003 | A1 |
20030191396 | Sanghvi | Oct 2003 | A1 |
20030200481 | Stanley | Oct 2003 | A1 |
20030212129 | Liu et al. | Nov 2003 | A1 |
20030212351 | Hissong | Nov 2003 | A1 |
20030212393 | Knowlton | Nov 2003 | A1 |
20030216795 | Harth | Nov 2003 | A1 |
20030220536 | Hissong | Nov 2003 | A1 |
20030220585 | Hissong | Nov 2003 | A1 |
20030229331 | Brisken et al. | Dec 2003 | A1 |
20030233085 | Giammarusti | Dec 2003 | A1 |
20030236487 | Knowlton | Dec 2003 | A1 |
20040000316 | Knowlton | Jan 2004 | A1 |
20040001809 | Brisken | Jan 2004 | A1 |
20040002705 | Knowlton | Jan 2004 | A1 |
20040010222 | Nunomura et al. | Jan 2004 | A1 |
20040015106 | Coleman | Jan 2004 | A1 |
20040030227 | Littrup | Feb 2004 | A1 |
20040039312 | Hillstead | Feb 2004 | A1 |
20040039418 | Elstrom et al. | Feb 2004 | A1 |
20040041563 | Lewin et al. | Mar 2004 | A1 |
20040041880 | Ikeda et al. | Mar 2004 | A1 |
20040042168 | Yang et al. | Mar 2004 | A1 |
20040044375 | Diederich et al. | Mar 2004 | A1 |
20040049134 | Tosaya et al. | Mar 2004 | A1 |
20040049734 | Simske | Mar 2004 | A1 |
20040059266 | Fry | Mar 2004 | A1 |
20040068186 | Ishida et al. | Apr 2004 | A1 |
20040073079 | Altshuler et al. | Apr 2004 | A1 |
20040073113 | Salgo | Apr 2004 | A1 |
20040073115 | Horzewski et al. | Apr 2004 | A1 |
20040073116 | Smith | Apr 2004 | A1 |
20040073204 | Ryan et al. | Apr 2004 | A1 |
20040077977 | Ella et al. | Apr 2004 | A1 |
20040082857 | Schonenberger et al. | Apr 2004 | A1 |
20040082859 | Schaer | Apr 2004 | A1 |
20040102697 | Evron | May 2004 | A1 |
20040105559 | Aylward et al. | Jun 2004 | A1 |
20040122323 | Vortman et al. | Jun 2004 | A1 |
20040122493 | Ishibashi et al. | Jun 2004 | A1 |
20040143297 | Ramsey | Jul 2004 | A1 |
20040152982 | Hwang et al. | Aug 2004 | A1 |
20040158150 | Rabiner et al. | Aug 2004 | A1 |
20040186535 | Knowlton | Sep 2004 | A1 |
20040189155 | Funakubo | Sep 2004 | A1 |
20040206365 | Knowlton | Oct 2004 | A1 |
20040210214 | Knowlton | Oct 2004 | A1 |
20040217675 | Desilets | Nov 2004 | A1 |
20040249318 | Tanaka | Dec 2004 | A1 |
20040254620 | Lacoste et al. | Dec 2004 | A1 |
20040267252 | Washington et al. | Dec 2004 | A1 |
20050033201 | Takahashi | Feb 2005 | A1 |
20050033316 | Kertz | Feb 2005 | A1 |
20050038340 | Vaezy et al. | Feb 2005 | A1 |
20050055073 | Weber | Mar 2005 | A1 |
20050061834 | Garcia et al. | Mar 2005 | A1 |
20050070961 | Maki et al. | Mar 2005 | A1 |
20050074407 | Smith | Apr 2005 | A1 |
20050080469 | Larson | Apr 2005 | A1 |
20050091770 | Mourad et al. | May 2005 | A1 |
20050096542 | Weng et al. | May 2005 | A1 |
20050104690 | Larson, III et al. | May 2005 | A1 |
20050113689 | Gritzky | May 2005 | A1 |
20050134314 | Prather et al. | Jun 2005 | A1 |
20050137656 | Malak | Jun 2005 | A1 |
20050143677 | Young et al. | Jun 2005 | A1 |
20050154313 | Desilets | Jul 2005 | A1 |
20050154314 | Quistgaard | Jul 2005 | A1 |
20050154332 | Zanelli | Jul 2005 | A1 |
20050154431 | Quistgaard | Jul 2005 | A1 |
20050187495 | Quistgaard | Aug 2005 | A1 |
20050191252 | Mitsui | Sep 2005 | A1 |
20050193451 | Quistgaard et al. | Sep 2005 | A1 |
20050197681 | Barolet et al. | Sep 2005 | A1 |
20050228281 | Nefos | Oct 2005 | A1 |
20050240170 | Zhang et al. | Oct 2005 | A1 |
20050251120 | Anderson et al. | Nov 2005 | A1 |
20050256406 | Barthe | Nov 2005 | A1 |
20050261584 | Eshel | Nov 2005 | A1 |
20050261585 | Makin et al. | Nov 2005 | A1 |
20050267454 | Hissong | Dec 2005 | A1 |
20050288748 | Li et al. | Dec 2005 | A1 |
20060004306 | Altshuler | Jan 2006 | A1 |
20060020260 | Dover et al. | Jan 2006 | A1 |
20060025756 | Francischelli | Feb 2006 | A1 |
20060042201 | Curry | Mar 2006 | A1 |
20060058664 | Barthe | Mar 2006 | A1 |
20060058671 | Vitek et al. | Mar 2006 | A1 |
20060058707 | Barthe | Mar 2006 | A1 |
20060058712 | Altshuler et al. | Mar 2006 | A1 |
20060074309 | Bonnefous | Apr 2006 | A1 |
20060074313 | Slayton et al. | Apr 2006 | A1 |
20060074314 | Slayton | Apr 2006 | A1 |
20060074355 | Slayton | Apr 2006 | A1 |
20060079816 | Barthe | Apr 2006 | A1 |
20060079868 | Makin | Apr 2006 | A1 |
20060084891 | Barthe | Apr 2006 | A1 |
20060089632 | Barthe | Apr 2006 | A1 |
20060089688 | Panescu | Apr 2006 | A1 |
20060094988 | Tosaya et al. | May 2006 | A1 |
20060111744 | Makin | May 2006 | A1 |
20060116583 | Ogasawara et al. | Jun 2006 | A1 |
20060116671 | Slayton | Jun 2006 | A1 |
20060122508 | Slayton | Jun 2006 | A1 |
20060122509 | Desilets | Jun 2006 | A1 |
20060161062 | Arditi | Jul 2006 | A1 |
20060184069 | Vaitekunas | Aug 2006 | A1 |
20060184071 | Klopotek | Aug 2006 | A1 |
20060189972 | Grossman | Aug 2006 | A1 |
20060206105 | Chopra | Sep 2006 | A1 |
20060229514 | Wiener | Oct 2006 | A1 |
20060241440 | Eshel | Oct 2006 | A1 |
20060241442 | Barthe | Oct 2006 | A1 |
20060241470 | Novak et al. | Oct 2006 | A1 |
20060250046 | Koizumi et al. | Nov 2006 | A1 |
20060261584 | Blackburn | Nov 2006 | A1 |
20060282691 | Barthe | Dec 2006 | A1 |
20060291710 | Wang et al. | Dec 2006 | A1 |
20070032784 | Gliklich et al. | Feb 2007 | A1 |
20070035201 | Desilets | Feb 2007 | A1 |
20070055154 | Torbati | Mar 2007 | A1 |
20070055155 | Owen et al. | Mar 2007 | A1 |
20070055156 | Desilets et al. | Mar 2007 | A1 |
20070065420 | Johnson | Mar 2007 | A1 |
20070083120 | Cain et al. | Apr 2007 | A1 |
20070087060 | Dietrich | Apr 2007 | A1 |
20070088245 | Babaev et al. | Apr 2007 | A1 |
20070088346 | Mirizzi et al. | Apr 2007 | A1 |
20070161902 | Dan | Jul 2007 | A1 |
20070166357 | Shaffer et al. | Jul 2007 | A1 |
20070167709 | Slayton | Jul 2007 | A1 |
20070208253 | Slayton | Sep 2007 | A1 |
20070219604 | Yaroslavsky et al. | Sep 2007 | A1 |
20070219605 | Yaroslavsky et al. | Sep 2007 | A1 |
20070238994 | Stecco et al. | Oct 2007 | A1 |
20070239075 | Rosenberg et al. | Oct 2007 | A1 |
20070239079 | Manstein et al. | Oct 2007 | A1 |
20070239142 | Altshuler et al. | Oct 2007 | A1 |
20080027328 | Klopotek et al. | Jan 2008 | A1 |
20080039724 | Seip et al. | Feb 2008 | A1 |
20080071255 | Barthe | Mar 2008 | A1 |
20080086054 | Slayton | Apr 2008 | A1 |
20080097253 | Pedersen | Apr 2008 | A1 |
20080139974 | Da Silva | Jun 2008 | A1 |
20080146970 | Litman et al. | Jun 2008 | A1 |
20080167556 | Thompson et al. | Jul 2008 | A1 |
20080183077 | Moreau-Gobard et al. | Jul 2008 | A1 |
20080188745 | Chen et al. | Aug 2008 | A1 |
20080195000 | Spooner et al. | Aug 2008 | A1 |
20080200810 | Buchalter | Aug 2008 | A1 |
20080200813 | Quistgaard | Aug 2008 | A1 |
20080214966 | Slayton | Sep 2008 | A1 |
20080221491 | Slayton | Sep 2008 | A1 |
20080223379 | Stuker et al. | Sep 2008 | A1 |
20080243035 | Crunkilton | Oct 2008 | A1 |
20080269608 | Anderson et al. | Oct 2008 | A1 |
20080275342 | Barthe | Nov 2008 | A1 |
20080281206 | Bartlett et al. | Nov 2008 | A1 |
20080281236 | Eshel et al. | Nov 2008 | A1 |
20080281237 | Slayton | Nov 2008 | A1 |
20080281255 | Slayton | Nov 2008 | A1 |
20080294073 | Barthe | Nov 2008 | A1 |
20080319356 | Cain et al. | Dec 2008 | A1 |
20090005680 | Jones et al. | Jan 2009 | A1 |
20090012394 | Hobelsberger et al. | Jan 2009 | A1 |
20090043198 | Milner et al. | Feb 2009 | A1 |
20090043293 | Pankratov et al. | Feb 2009 | A1 |
20090069677 | Chen et al. | Mar 2009 | A1 |
20090093737 | Chomas et al. | Apr 2009 | A1 |
20090156969 | Santangelo | Jun 2009 | A1 |
20090171252 | Bockenstedt et al. | Jul 2009 | A1 |
20090177122 | Peterson | Jul 2009 | A1 |
20090177123 | Peterson | Jul 2009 | A1 |
20090182231 | Barthe et al. | Jul 2009 | A1 |
20090216159 | Slayton et al. | Aug 2009 | A1 |
20090226424 | Hsu | Sep 2009 | A1 |
20090227910 | Pedersen et al. | Sep 2009 | A1 |
20090253988 | Slayton et al. | Oct 2009 | A1 |
20090299175 | Bernstein et al. | Dec 2009 | A1 |
20090318909 | Debenedictis et al. | Dec 2009 | A1 |
20100011236 | Barthe et al. | Jan 2010 | A1 |
20100022919 | Peterson | Jan 2010 | A1 |
20100022922 | Barthe et al. | Jan 2010 | A1 |
20100042020 | Ben-Ezra | Feb 2010 | A1 |
20100049178 | Deem et al. | Feb 2010 | A1 |
20100063422 | Hynynen et al. | Mar 2010 | A1 |
20100130891 | Taggart et al. | May 2010 | A1 |
20100160782 | Slayton et al. | Jun 2010 | A1 |
20100160837 | Hunziker et al. | Jun 2010 | A1 |
20100168576 | Poland et al. | Jul 2010 | A1 |
20100191120 | Kraus et al. | Jul 2010 | A1 |
20100241035 | Barthe et al. | Sep 2010 | A1 |
20100280420 | Barthe et al. | Nov 2010 | A1 |
20100286518 | Lee et al. | Nov 2010 | A1 |
20110040171 | Foley et al. | Feb 2011 | A1 |
20110040190 | Jahnke et al. | Feb 2011 | A1 |
20110087099 | Eshel et al. | Apr 2011 | A1 |
20110087255 | Mccormack et al. | Apr 2011 | A1 |
20110112405 | Barthe et al. | May 2011 | A1 |
20110178444 | Slayton et al. | Jul 2011 | A1 |
20110190745 | Uebelhoer et al. | Aug 2011 | A1 |
20110264012 | Lautzenhiser et al. | Oct 2011 | A1 |
20120004549 | Barthe et al. | Jan 2012 | A1 |
20120016239 | Barthe et al. | Jan 2012 | A1 |
20120029353 | Slayton et al. | Feb 2012 | A1 |
20120035475 | Barthe et al. | Feb 2012 | A1 |
20120035476 | Barthe et al. | Feb 2012 | A1 |
20120046547 | Barthe et al. | Feb 2012 | A1 |
20120053458 | Barthe et al. | Mar 2012 | A1 |
20120111339 | Barthe et al. | May 2012 | A1 |
20120143056 | Slayton et al. | Jun 2012 | A1 |
20120165668 | Slayton et al. | Jun 2012 | A1 |
20120165848 | Slayton et al. | Jun 2012 | A1 |
20120197120 | Makin et al. | Aug 2012 | A1 |
20120197121 | Slayton et al. | Aug 2012 | A1 |
20120215105 | Slayton et al. | Aug 2012 | A1 |
20120271294 | Barthe et al. | Oct 2012 | A1 |
20120296240 | Azhari et al. | Nov 2012 | A1 |
20120316426 | Foley et al. | Dec 2012 | A1 |
20120330197 | Makin et al. | Dec 2012 | A1 |
20120330222 | Barthe et al. | Dec 2012 | A1 |
20120330223 | Makin et al. | Dec 2012 | A1 |
20130012755 | Slayton | Jan 2013 | A1 |
20130012816 | Slayton et al. | Jan 2013 | A1 |
20130012838 | Jaeger et al. | Jan 2013 | A1 |
20130012842 | Barthe | Jan 2013 | A1 |
20130018286 | Slayton et al. | Jan 2013 | A1 |
20130046209 | Slayton et al. | Feb 2013 | A1 |
20130066208 | Barthe et al. | Mar 2013 | A1 |
20130066237 | Smotrich et al. | Mar 2013 | A1 |
20130072826 | Slayton et al. | Mar 2013 | A1 |
20130096471 | Slayton et al. | Apr 2013 | A1 |
20130190659 | Slayton et al. | Jul 2013 | A1 |
20130211258 | Barthe et al. | Aug 2013 | A1 |
20130281853 | Slayton et al. | Oct 2013 | A1 |
20130281891 | Slayton et al. | Oct 2013 | A1 |
20130296697 | Slayton et al. | Nov 2013 | A1 |
20130296700 | Slayton et al. | Nov 2013 | A1 |
20130303904 | Barthe et al. | Nov 2013 | A1 |
20130303905 | Barthe et al. | Nov 2013 | A1 |
20130310863 | Barthe et al. | Nov 2013 | A1 |
20140082907 | Barthe | Mar 2014 | A1 |
20140142430 | Slayton et al. | May 2014 | A1 |
20140148834 | Barthe et al. | May 2014 | A1 |
20140180174 | Slayton et al. | Jun 2014 | A1 |
20140187944 | Slayton et al. | Jul 2014 | A1 |
20140188015 | Slayton et al. | Jul 2014 | A1 |
20140188145 | Slayton et al. | Jul 2014 | A1 |
Number | Date | Country |
---|---|---|
4029175 | Mar 1992 | DE |
10140064 | Mar 2003 | DE |
10219217 | Nov 2003 | DE |
10219297 | Nov 2003 | DE |
20314479 | Mar 2004 | DE |
0344773 | Dec 1989 | EP |
1479412 | Nov 1991 | EP |
0473553 | Apr 1992 | EP |
0661029 | Jul 1995 | EP |
1050322 | Nov 2000 | EP |
1234566 | Aug 2002 | EP |
1262160 | Dec 2002 | EP |
1374944 | Jan 2004 | EP |
2113099 | Aug 1983 | GB |
63036171 | Feb 1988 | JP |
03048299 | Mar 1991 | JP |
3123559 | May 1991 | JP |
03136642 | Jun 1991 | JP |
4089058 | Mar 1992 | JP |
04150847 | May 1992 | JP |
7080087 | Mar 1995 | JP |
07505793 | Jun 1995 | JP |
7222782 | Aug 1995 | JP |
09047458 | Feb 1997 | JP |
11505440 | May 1999 | JP |
11506636 | Jun 1999 | JP |
2000166940 | Jun 2000 | JP |
2001170068 | Jun 2001 | JP |
2002515786 | May 2002 | JP |
2002521118 | Jul 2002 | JP |
2002537939 | Nov 2002 | JP |
2003050298 | Feb 2003 | JP |
2002078764 | Mar 2003 | JP |
2003204982 | Jul 2003 | JP |
2004147719 | May 2004 | JP |
2005503388 | Feb 2005 | JP |
2005527336 | Sep 2005 | JP |
2005323213 | Nov 2005 | JP |
2006520247 | Sep 2006 | JP |
2007505793 | Mar 2007 | JP |
2009518126 | May 2009 | JP |
2010517695 | May 2010 | JP |
1020010024871 | Mar 2001 | KR |
100400870 | Oct 2003 | KR |
1020060113930 | Nov 2006 | KR |
1020070065332 | Jun 2007 | KR |
1020070070161 | Jul 2007 | KR |
1020070098856 | Oct 2007 | KR |
1020070104878 | Oct 2007 | KR |
1020070114105 | Nov 2007 | KR |
9625888 | Aug 1996 | WO |
9639079 | Dec 1996 | WO |
9735518 | Oct 1997 | WO |
9832379 | Jul 1998 | WO |
9933520 | Jul 1999 | WO |
9949788 | Oct 1999 | WO |
0006032 | Feb 2000 | WO |
0015300 | Mar 2000 | WO |
0021612 | Apr 2000 | WO |
0053113 | Sep 2000 | WO |
0128623 | Apr 2001 | WO |
0182777 | Nov 2001 | WO |
0182778 | Nov 2001 | WO |
0187161 | Nov 2001 | WO |
0209813 | Feb 2002 | WO |
02024050 | Mar 2002 | WO |
02092168 | Nov 2002 | WO |
020292168 | Nov 2002 | WO |
03053266 | Jul 2003 | WO |
03065347 | Aug 2003 | WO |
03070105 | Aug 2003 | WO |
03077833 | Aug 2003 | WO |
03086215 | Oct 2003 | WO |
03096883 | Nov 2003 | WO |
03099177 | Dec 2003 | WO |
03101530 | Dec 2003 | WO |
2004000116 | Dec 2003 | WO |
2004080147 | Sep 2004 | WO |
2004110558 | Dec 2004 | WO |
2005011804 | Feb 2005 | WO |
2005065408 | Jul 2005 | WO |
2005090978 | Sep 2005 | WO |
2006036870 | Apr 2006 | WO |
2006042163 | Apr 2006 | WO |
2006042168 | Apr 2006 | WO |
2006042201 | Apr 2006 | WO |
2006065671 | Jun 2006 | WO |
2006082573 | Aug 2006 | WO |
2007067563 | Jun 2007 | WO |
2008024923 | Feb 2008 | WO |
2008036622 | Mar 2008 | WO |
2009013729 | Jan 2009 | WO |
2009149390 | Dec 2009 | WO |
2014055708 | Apr 2014 | WO |
Entry |
---|
Arthur et al., “Non-invasive estimation of hyperthermia temperatures with ultrasound,” Int. J. Hyperthermia, Sep. 2005, 21(6), pp. 589-600. |
Chen, L. et al., “Effect of Blood Perfusion on the ablation of liver perenchyma with high intensity focused ultrasound,” Phys. Med. Biol; 38:1661-1673; 1993b. |
Damianou et al., Application of the Thermal Dose Concept for Predicting the Necrosed Tissue Volume During Ultrasound Surgery, 1993 IEEE Ultrasound Symposium, pp. 1199-1202. |
Fry, W.J. et al., “Production of Focal Destructive Lesions in the Central Nervous System with Ultrasound,” J. Neurosurg., 11:471-478; 1954. |
Harr, G.R. et al., “Tissue Destruction with Focused Ultrasound in Vivo,” Eur. Urol. 23 (suppl. 1):8-11; 1993. |
Jeffers et al., “Evaluation of the Effect of Cavitation Activity on Drug-Ultrasound Synergisms,” 1993 IEEE Ultrasonics Symposium, pp. 925-928. |
Madersbacher, S. et al., “Tissue Ablation in Bening Prostatic Hyperplasia with High Intensity Focused Ultrasound,” Dur. Urol., 23 (suppl. 1):39-43; 1993. |
Saad et al., “Ultrasound-Enhanced Effects of Adriamycin Against Murine Tumors,” Ultrasound in Med. & Biol. vol. 18, No. 8, pp. 715-723 (1992). |
Simon et al., “Applications of Lipid-Coated Microbubble Ultrasonic Contrast to Tumor Therapy,” Ultrasound in Med. & Biol. vol. 19, No. 2, pp. 123-125 (1993). |
Talbert, D. G., “An Add-On Modification for Linear Array Real-Time Ultrasound Scanners to Produce 3D Displays,” UTS Int'l 1977 Brighton, England (Jun. 28-30, 1977) pp. 57-67. |
Tata et al., “Interaction of Ultrasound and Model Membrane Systems: Analyses and Predictions,” American Chemical Society, Phys. Chem. 1992, 96, pp. 3548-3555. |
Alster, Tinas S., Tanzi, Elizabeth L., “Cellulite Treatment using a Novel Combination Radiofrequency, Infrared Light, and Mechanical Tissue Manipulation Device,” Journal of Cosmetic & Laser Therapy, Jun. 2005, vol. 7, Issue 2, pp. 81-85. |
Barthe et al., “Ultrasound therapy system and abiation results utilizing miniature imaging/therapy arrays,” Ultrasonics Symposium, 2004 IEEE, Aug. 23, 2004, pp. 1792-1795, vol. 3. |
Coon, Joshua et al., “Protein identification using sequential ion/ion reactions and tandem mass spectometry” Proceedings of the National Academy of Sciences of the USA, vol. 102, No. 27, Jul. 5, 2005, pp. 9463-9468. |
Corry, Peter M., et al., “Human Cancer Treatment with Ultrasound”, IEEE Transactions on Sonics and Ultrasonics, vol. SU-31, No. 5, Sep. 1984, pp. 444,456. |
Daum et al., “Design and Evaluation of a Feedback Based Phased Array System for Ultrasound Surgery,” IEEE Transactions on Ultrasonics, Feroelectronics, and Frequency Control, vol. 45, No. 2, Mar. 1998, pp. 431-438. |
Davis, Brian J., et al., “An Acoustic Phase Shift Technique for the Non-Invasive Measurement of Temperature Changes in Tissues”, 1985 Ultrasonics Symposium, pp. 921-924. |
Gliklich et al., Clinical Pilot Study of Intense Ultrasound therapy to Deep Dermal Facial Skin and Subcutaneous Tissues, Arch Facial Plastic Surgery, Mar. 1, 2007, vol. 9. |
Hassan et al., “Structure and Applications of Poly(vinyl alcohol) Hydrogels Produced by Conventional Crosslinking or by Freezing/Thawing Methods,” advanced in Polymer Science, 2000, pp. 37-65, vol. 153. |
Hassan et al., “Structure and Morphology of Freeze/Thawed PVA Hydrogels,” Macromolecules, Mar. 11, 2000, pp. 2472-2479, vol. 33, No. 7. |
Husseini et al, “The Role of Cavitation in Acoustically Activated Drug Delivery,” J. Control Release, Oct. 3, 2005, pp. 253-261, vol. 107(2). |
Husseini et al. “Investigating the mechanism of accoustically activated uptake of drugs from Pluronic micelles,” BMD Cancer 2002, 2:20k, Aug. 30, 2002, pp. 1-6. |
Jenne, J., et al., “Temperature Mapping for High Energy US-Therapy”, 1994 Ultrasonics Symposium, pp. 1879-1882. |
Johnson, S.A., et al., “Non-Intrusive Measurement of Microwave and Ultrasound-Induced Hyperthermia by Acoustic temperature Tomography”, Ultrasonics Symposium Proceedings, pp. 977-982. |
Makin et al, “B-Scan Imaging and Thermal Lesion Monitoring Using Miniaturized Dual-Functionality Ultrasound Arrays,” Ultrasonics Symposium, 2004 IEEE, Aug. 23, 2004, pp. 1788-1791, vol. 3. |
Makin et al, “Miniaturized Ultrasound Arrays for Interstitial Ablation and Imaging,” UltraSound Med. Biol. 2005, Nov. 1, 2005, pp. 1539-1550, vol. 31(11). |
Makin et al., “Confirmal Bulk Ablation and Therapy Monitoring Using Intracorporeal Image-Treat Ultrasound Arrays”, 4th International Symposium on Therapeutic Ultrasound, Sep. 19, 2004. |
Manohar et al, “Photoaccoustic mammography laboratory prototype: imaging of breast tissue phantoms,” Journal of Biomedical Optics, Nov./Dec. 2004, pp. 1172-1181, vol. 9, No. 6. |
Mast et al, “Bulk Ablation of Soft Tissue with Intense Ultrasound; Modeling nad Experiments,” J. Acoust. Soc. Am., Oct. 1, 2005, pp. 2715-2724, vol. 118(4). |
Paradossi et al., “Poly(vinyl alcohol) as versatile biomaterial for potential biomedical applications,” Journal of Materials Science: Materials in Medicine, 2003, pp. 687-691, vol. 14. |
Reid, Gavin, et al., “Tandem Mass spectrometry of ribonuclease A and B: N-linked glycosylation site analysis of whole protein ions,” Analytical Chemistry. Feb. 1, 2002, vol. 74, No. 3, pp. 577-583. |
Righetti et al, “Elastographic Characterization of HIFU-Induced Lesions in Canine Livers,” 1999, Ultrasound in Med & Bio, vol. 25, No. 7, pp. 1099-1113. |
Mitragotri, Samir; “Healing sound: the use of ultrasound in drug delivery and other therapeutic applications,” Nature Reviews; Drug Delivery, pp. 255-260, vol. 4. |
Sanghvi, N. T., et al., “Transrectal Ablation of Prostrate Tissue Using Focused Ultrasound,” 1993 Ultrasonics Symposium, IEEE, pp. 1207-1210. |
Seip, Ralf, et al., “Noninvasive Detection of Thermal Effects Due to Highly Focused Ultrasonic Fiels,” IEEE Symposium, pp. 1229-1232, vol. 2, Oct. 3-Nov. 1993. |
Seip, Ralf, et al., “Noninvasive Estimation of Tissue Temperature Response to Heating Fields Using Diagnostic Ultrasound,” IEEE Transactions on Biomedical Engineering, vol. 42, No. 8, Aug. 1995, pp. 828-839. |
Smith, Nadine Barrie, et al., “Non-Invasive in Vivo Temperature Mapping of Ultrasound Heating Using Magnetic Resonance Techniques”, 1994 Ultrasonics Symposium, pp. 1829-1832, vol. 3. |
Surry et al., “Poly(vinyl alcohol) cryogel phantoms for use in ultrasound and MR imaging,” Phys. Med. Biol., Dec. 6, 2004, pp. 5529-5546, vol. 49. |
Syka J. E. P. et al., “Peptide and Protein Sequence Analysis by Electron Transfer Dissociation Mass Spectometry,” Proceedings of the National Academy of Sciences of USA, National Academy of Aceince, Washington, DC, vol. 101, No. 26, Jun. 29, 2004, pp. 9528-9533. |
Ueno, S., et al., “Ultrasound Thermometry in Hyperthermia”, 1990 Ultrasonic Symposium, pp. 1645-1652. |
Wang, H., et al., “Limits on Focused Ultrasound for Deep Hyperthermia”, 1994 Ultrasonic Symposium, Nov. 1-4, 1994, pp. 1869-1872, vol. 3. |
White et al “Selective Creation of Thermal Injury Zones in the Superficial Musculoaponeurotic System Using Intense Ultrasound Therapy,” Arch Facial Plastic Surgery, Jan./Feb. 2007, vol. 9, No. 1. |
Sassen, Sander, “ATI's R520 architecture, the new king of the hill?” http://www.hardwareanalysis.com/content/article/1813, Sep. 16, 2005, 2 pages. |
Wasson, Scott, “NVIDIA's GeFroce 7800 GTX graphics processor Power MADD,” http://techreport.com/reviews/2005q2/geforce-7800gtx/index.x?pg=1, Jun. 22, 2005, 4 pages. |
European Examination Report in related Application No. 05808908.7 dated Jun. 29, 2009. |
European Examination Report in related Application No. 05810308.6 dated Jun. 29, 2009. |
European Examination Report in related Application No. 10185100.4 dated Jan. 6, 2014. |
European Examination Report in related Application No. 10185120.2 dated Jan. 22, 2014. |
Decision of the Korean Intellectual Property Tribunal dated Jun. 28, 2013 regarding Korean Patent No. 10-1142108, which is related to the pending application and/or an application identified in the Table on the pp. 2-5 of the information Disclosure Statement herein (English translation, English translation certification, and Korean decision included). |
International Search Report and Written Opinion dated Jan. 23, 2014 in Application No. PCT/US2012/046122. |
International Search Report and Written Opinion dated Jan. 23, 2014 in Application No. PCT/US2012/046123. |
International Search Report and Written Opinion dated Jan. 28, 2012 in Application No. PCT/US2012/046327. |
International Search Report and Written Opinion dated Jan. 28, 2013 in Application No. PCT/US2012/046125. |
International Search Report and Written Opinion dated Feb. 14, 2013 in Application No. PCT/US2011/001361. |
International Search Report and Written Opinion dated Feb. 14, 2013 in Application No. PCT/US2011/001362. |
International Search Report and Written Opinion dated Feb. 14, 2013 in Application No. PCT/US2011/001366. |
International Search Report and Written Opinion dated Apr. 6, 2012 in Application No. PCT/US2011/001367. |
Calderhead, et al., One Mechanism Behind LED Photo-Therapy for Wound Healing and Skin Rejuvenation: Key Role of the Mast Cell, Laser Therapy, 2008, 17.3:141-148. |
PCT International Preliminary Report on Patentability, PCT/US2011/001366, Feb. 14, 2013, 6 pages. |
European Patent Office, Extended Search Report, EP 09835856.7, Apr. 11, 2014, 6 pages. |
PCT International Search Report and Written Opinion, PCT/US2014/030779, Sep. 1, 2014, 8 pages. |
European Patent Office, Examination Report, EP 07814933.3, Aug. 5, 2014, 5 pages. |
European Patent Office, Examination Report, EP 05798870.1, Oct. 20, 2014, 5 pages. |
European Patent Office, Examination Report, EP 10185100.4, Oct. 24, 2014, 4 pages. |
European Patent Office, Examination Report, EP 10185112.9, Oct. 24, 2014, 5 pages. |
European Patent Office, Examination Report, EP 10185117.8, Oct. 24, 2014, 5 pages. |
European Patent Office, Examination Report, EP 10185120.2, Oct. 24, 2014, 4 pages. |
Number | Date | Country | |
---|---|---|---|
20130018286 A1 | Jan 2013 | US |
Number | Date | Country | |
---|---|---|---|
61506609 | Jul 2011 | US | |
61506610 | Jul 2011 | US |